Partners

Our Approach to Partnerships

G1 is focused on discovering, developing and delivering innovative therapies that improve the lives of those affected by cancer. We have in-house discovery, clinical and commercialization capabilities, and are seeking collaboration and in-licensing opportunities that will help us advance the treatment of cancer and enable global access to innovative medicines.

If you are interested in exploring partnerships with G1, please contact us at partner@g1therapeutics.com.

Our Partners

genentech logo

We have a non-exclusive clinical trial collaboration for trilaciclib/chemotherapy/Tecentriq® (atezolizumab) in multiple indications. Click here to learn more about trilaciclib, and here for information on ongoing clinical trials.

astra zeneca logo

We have a non-exclusive clinical trial collaboration for lerociclib/Tagrisso® (osimertinib) in EGFRm non-small cell lung cancer. Click here to learn more about lerociclib, and here for more information on ongoing clinical trials.